Marubi reinvests yuan 35m in new structured deposit

Guangdong Marubi Biotechnology Co., Ltd. (Marubi) announced the redemption of its Chongqing Bank Structured Deposit 2024 Series 540, which matured on October 22, 2025. The company received its principal of yuan 35 million and a return of yuan 0.8575 million from this investment.

Following this redemption, Marubi immediately reinvested yuan 35 million of its idle raised funds into another Chongqing Bank Structured Deposit, the 2025 Series 457, with a term of 365 days. This new product is a capital-protected floating income type with an expected annualized yield of 1.50%, 1.85%, or 2.05%, depending on market conditions. The investment is part of the company's approved strategy to manage up to yuan 200 million in idle raised funds to enhance capital efficiency and generate returns for shareholders.

As of the announcement date, Marubi has utilized yuan 75 million of its authorized idle raised funds for cash management, including the latest transaction, remaining within the board-approved limit. This investment represents 2.18% of the company's total monetary funds of yuan 1,608.9234 million as of June 30, 2025.